tascenso odt

Generic: fingolimod lauryl sulfate

Labeler: cycle pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tascenso odt
Generic Name fingolimod lauryl sulfate
Labeler cycle pharmaceuticals ltd
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

fingolimod lauryl sulfate .25 mg/1

Manufacturer
Cycle Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 70709-062
Product ID 70709-062_eb717a3b-e703-4637-83c7-fccdecbac199
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA214962
Listing Expiration 2027-12-31
Marketing Start 2023-02-01

Pharmacologic Class

Classes
sphingosine 1-phosphate receptor modulators [moa] sphingosine 1-phosphate receptor modulator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70709062
Hyphenated Format 70709-062

Supplemental Identifiers

UPC
0370709062303
UNII
J3HZQ9BE2S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tascenso odt (source: ndc)
Generic Name fingolimod lauryl sulfate (source: ndc)
Application Number NDA214962 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .25 mg/1
source: ndc
Packaging
  • 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
source: ndc

Packages (1)

70709-062-30 3 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Ingredients (1)

fingolimod lauryl sulfate (.25 mg/1)

Linked Drug Pages (1)

TASCENSO ODT ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "eb717a3b-e703-4637-83c7-fccdecbac199", "openfda": {"upc": ["0370709062303"], "unii": ["J3HZQ9BE2S"], "spl_set_id": ["bf8e7f89-ea09-43c7-a7eb-e44724350721"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (70709-062-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "70709-062-30", "marketing_start_date": "20230201"}], "brand_name": "TASCENSO ODT", "product_id": "70709-062_eb717a3b-e703-4637-83c7-fccdecbac199", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Sphingosine 1-Phosphate Receptor Modulators [MoA]", "Sphingosine 1-phosphate Receptor Modulator [EPC]"], "product_ndc": "70709-062", "generic_name": "Fingolimod Lauryl Sulfate", "labeler_name": "Cycle Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TASCENSO ODT", "active_ingredients": [{"name": "FINGOLIMOD LAURYL SULFATE", "strength": ".25 mg/1"}], "application_number": "NDA214962", "marketing_category": "NDA", "marketing_start_date": "20230201", "listing_expiration_date": "20271231"}